Iovance Biotherapeutics, Inc. Earnings

Iovance Biotherapeutics, Inc.’s revenue jumped 17.74% since last year same period to $86.77Mn in the Q4 2025. On a quarterly growth basis, Iovance Biotherapeutics, Inc. has generated 28.64% jump in its revenue since last 3-months.

Iovance Biotherapeutics, Inc.’s net profit jumped 8.47% since last year same period to $-71.9Mn in the Q4 2025. On a quarterly growth basis, Iovance Biotherapeutics, Inc. has generated 21.2% jump in its net profits since last 3-months.

Iovance Biotherapeutics, Inc.’s net profit margin jumped 22.27% since last year same period to -82.87% in the Q4 2025. On a quarterly growth basis, Iovance Biotherapeutics, Inc. has generated 38.74% jump in its net profit margins since last 3-months.

Iovance Biotherapeutics, Inc.’s earning per share (EPS) estimates for the current quarter stand at -0.18 - a 32.59% jump from last quarter’s estimates.

Iovance Biotherapeutics, Inc.’s earning per share (EPS) estimates for the current year stand at -0.18.

Iovance Biotherapeutics, Inc.’s earning per share (EPS) jumped 30.77% since last year same period to -0.18 in the Q4 2025. This indicates that the Iovance Biotherapeutics, Inc. has generated 30.77% annual rate of jump in its earning per share (EPS) in the last 4 quarters.